Last reviewed · How we verify
Skin Autograft — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Skin Autograft (Skin Autograft) — Andalusian Network for Design and Translation of Advanced Therapies.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Skin Autograft TARGET | Skin Autograft | Andalusian Network for Design and Translation of Advanced Therapies | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Skin Autograft CI watch — RSS
- Skin Autograft CI watch — Atom
- Skin Autograft CI watch — JSON
- Skin Autograft alone — RSS
Cite this brief
Drug Landscape (2026). Skin Autograft — Competitive Intelligence Brief. https://druglandscape.com/ci/skin-autograft. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab